MURA vs. IXHL, DSGN, RANI, BMEA, TSVT, VTYX, ZVRA, GLSI, ME, and VACC
Should you be buying Mural Oncology stock or one of its competitors? The main competitors of Mural Oncology include Incannex Healthcare (IXHL), Design Therapeutics (DSGN), Rani Therapeutics (RANI), Biomea Fusion (BMEA), 2seventy bio (TSVT), Ventyx Biosciences (VTYX), Zevra Therapeutics (ZVRA), Greenwich LifeSciences (GLSI), 23andMe (ME), and Vaccitech (VACC). These companies are all part of the "pharmaceutical preparations" industry.
Incannex Healthcare (NASDAQ:IXHL) and Mural Oncology (NASDAQ:MURA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, analyst recommendations, profitability, community ranking, institutional ownership and valuation.
Mural Oncology received 1 more outperform votes than Incannex Healthcare when rated by MarketBeat users.
Incannex Healthcare has higher revenue and earnings than Mural Oncology.
Mural Oncology has a consensus price target of $13.00, indicating a potential upside of 293.94%. Given Incannex Healthcare's higher possible upside, analysts plainly believe Mural Oncology is more favorable than Incannex Healthcare.
In the previous week, Incannex Healthcare and Incannex Healthcare both had 1 articles in the media. Incannex Healthcare's average media sentiment score of 1.89 beat Mural Oncology's score of 1.87 indicating that Mural Oncology is being referred to more favorably in the news media.
0.4% of Incannex Healthcare shares are owned by institutional investors. Comparatively, 80.2% of Mural Oncology shares are owned by institutional investors. 14.6% of Incannex Healthcare shares are owned by company insiders. Comparatively, 0.1% of Mural Oncology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
Mural Oncology beats Incannex Healthcare on 5 of the 8 factors compared between the two stocks.
Get Mural Oncology News Delivered to You Automatically
Sign up to receive the latest news and ratings for MURA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MURA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Mural Oncology Competitors List
Related Companies and Tools
